GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celon Pharma SA (WAR:CLN) » Definitions » Buildings And Improvements

Celon Pharma (WAR:CLN) Buildings And Improvements : zł158.7 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Celon Pharma Buildings And Improvements?

Celon Pharma's quarterly buildings and improvements declined from Sep. 2024 (zł164.9 Mil) to Dec. 2024 (zł158.7 Mil) and declined from Dec. 2024 (zł158.7 Mil) to Mar. 2025 (zł158.7 Mil).

Celon Pharma's annual buildings and improvements declined from Dec. 2022 (zł147.4 Mil) to Dec. 2023 (zł146.8 Mil) but then increased from Dec. 2023 (zł146.8 Mil) to Dec. 2024 (zł158.7 Mil).

Celon Pharma Buildings And Improvements Historical Data

The historical data trend for Celon Pharma's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celon Pharma Buildings And Improvements Chart

Celon Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 177.49 146.08 147.42 146.77 158.71

Celon Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.66 149.66 164.89 158.71 158.71

Celon Pharma Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Celon Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celon Pharma SA (WAR:CLN) » Definitions » Buildings And Improvements
Comparable Companies
WAR:BGD WAR:HMP WAR:MDB WAR:CBD ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM
Traded in Other Exchanges
0RKX:UK 8RP:Germany
Address
Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092
Website
http://www.celonpharma.com
Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.

Celon Pharma Headlines

No Headlines